Britain approved Pfizer Inc's COVID-19 vaccine on Wednesday, jumping ahead of the rest of the world in the race to begin the most crucial mass inoculation programme in history.

Pfizer Inc is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents reviewed by Reuters ...

Experts emphasize that there has been no real change in the benefits or risks of the vaccines, which are quite safe and offer ...

Advisers to the Centers for Disease Control and Prevention didn’t specifically recommend vaccination but said people could ...

The panel’s decision still must go to the CDC’s interim director, Jim O’Neill, for sign-off. A former investor, critic of health regulations and Kennedy’s deputy at HHS, O’Neill recently took the lead ...

The Food and Drug Administration recently put new restrictions on this year’s shots from Pfizer, Moderna and Novavax ... pediatric and infectious disease specialists who say the vaccine is safe and ...

The panel, which is charged with making vaccine recommendations, declined to recommend COVID-19 vaccines, saying instead that people could make individual decisions ... issue at all and said the ...

Covid-19 has infected more than 235M people and killed over 4.8M globally. Here are the virus-related developments for October 4: ...

The president’s call for removal of the metal from childhood inoculations set off alarms. About half of shots for polio, ...

Pfizer's stock price is down materially from its 2021 highs, but it is also up notably from its April 2025 lows.

Pennsylvania then joined the newly-formed Northeast Public Health Collaborative, a group of health agencies from seven states setting their own vaccine and health guidelines. A similar coalition, the ...